Clinical Trial Update: Paclitaxel or Docetaxel in Treating Women With Advanced Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Paclitaxel and Docetaxel in women with advanced breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Aventis Pharmaceuticals | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED